Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 158

1.

Methylphenidate patterns among Medicaid youths.

Zito JM, Safer DJ, dosReis S, Magder LS, Riddle MA.

Psychopharmacol Bull. 1997;33(1):143-7.

PMID:
9133766
[PubMed - indexed for MEDLINE]
2.

Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland.

Zito JM, Safer DJ, dosReis S, Riddle MA.

J Am Acad Child Adolesc Psychiatry. 1998 Feb;37(2):179-84.

PMID:
9473914
[PubMed - indexed for MEDLINE]
3.

Trends in the prescribing of psychotropic medications to preschoolers.

Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F.

JAMA. 2000 Feb 23;283(8):1025-30.

PMID:
10697062
[PubMed - indexed for MEDLINE]
4.

Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.

Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.

Ann Pharmacother. 2008 Jan;42(1):24-31. Epub 2007 Nov 27.

PMID:
18042808
[PubMed - indexed for MEDLINE]
5.

[Use of methylphenidate among children in Iceland 1989-2006].

Zoëga H, Baldursson G, Halldórsson M.

Laeknabladid. 2007 Dec;93(12):825-32. Icelandic.

PMID:
18057472
[PubMed - indexed for MEDLINE]
6.

Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.

Marcus SC, Wan GJ, Kemner JE, Olfson M.

Arch Pediatr Adolesc Med. 2005 Jun;159(6):572-8. Erratum in: Arch Pediatr Adolesc Med. 2005 Sep;159(9):875.

PMID:
15939858
[PubMed - indexed for MEDLINE]
7.

Prevalence of and change in the prescription of methylphenidate in Israel over a 2-year period.

Fogelman Y, Vinker S, Guy N, Kahan E.

CNS Drugs. 2003;17(12):915-9.

PMID:
12962530
[PubMed - indexed for MEDLINE]
8.

Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed.

Preen DB, Calver J, Sanfilippo FM, Bulsara M, Holman CD.

Aust N Z J Public Health. 2007 Apr;31(2):120-6.

PMID:
17461001
[PubMed - indexed for MEDLINE]
9.

Prevalence variations in psychotropic treatment of children.

Zito JM, Safer DJ, Riddle MA, Johnson RE, Speedie SM, Fox M.

J Child Adolesc Psychopharmacol. 1998;8(2):99-105.

PMID:
9730075
[PubMed - indexed for MEDLINE]
10.

Methylphenidate use for attention deficit hyperactivity disorder in northern Israel--a controversial issue.

Fogelman Y, Kahan E.

Isr Med Assoc J. 2001 Dec;3(12):925-7.

PMID:
11794916
[PubMed - indexed for MEDLINE]
Free Article
11.

[Sociodemographic and clinical factors associated with compliance to methylphenidate treatment in children with attention deficit hyperactivity disorder].

Kiliç BG, Bilgiç A, Gürkan K, Aysev A.

Turk Psikiyatri Derg. 2007 Fall;18(3):207-13. Turkish.

PMID:
17853975
[PubMed - indexed for MEDLINE]
Free Article
12.

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.

Goldman LS, Genel M, Bezman RJ, Slanetz PJ.

JAMA. 1998 Apr 8;279(14):1100-7. Review.

PMID:
9546570
[PubMed - indexed for MEDLINE]
13.

Assessment of adherence measures with different stimulants among children and adolescents.

Sanchez RJ, Crismon ML, Barner JC, Bettinger T, Wilson JP.

Pharmacotherapy. 2005 Jul;25(7):909-17.

PMID:
16006269
[PubMed - indexed for MEDLINE]
14.

Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care.

Martin A, Van Hoof T, Stubbe D, Sherwin T, Scahill L.

Psychiatr Serv. 2003 Jan;54(1):72-7.

PMID:
12509670
[PubMed - indexed for MEDLINE]
15.

[Increasing trend in prescription of methylphenidate in general practices in the north-east of The Netherlands, 1998-2003].

Donker GA, Groenhof F, van der Veen WJ.

Ned Tijdschr Geneeskd. 2005 Jul 30;149(31):1742-7. Dutch.

PMID:
16114292
[PubMed - indexed for MEDLINE]
16.

Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.

Zito JM, Safer DJ, Zuckerman IH, Gardner JF, Soeken K.

Psychiatr Serv. 2005 Feb;56(2):157-63.

PMID:
15703342
[PubMed - indexed for MEDLINE]
17.

Treatment with stimulants among youths in a large California health plan.

Habel LA, Schaefer CA, Levine P, Bhat AK, Elliott G.

J Child Adolesc Psychopharmacol. 2005 Feb;15(1):62-7.

PMID:
15741787
[PubMed - indexed for MEDLINE]
18.

Stimulant dosage and age, race, and insurance type in a sample of children with attention-deficit/hyperactivity disorder.

Lipkin PH, Cozen MA, Thompson RE, Mostofsky SH.

J Child Adolesc Psychopharmacol. 2005 Apr;15(2):240-8.

PMID:
15910208
[PubMed - indexed for MEDLINE]
19.

Increased methylphenidate usage for attention deficit disorder in the 1990s.

Safer DJ, Zito JM, Fine EM.

Pediatrics. 1996 Dec;98(6 Pt 1):1084-8.

PMID:
8951257
[PubMed - indexed for MEDLINE]
20.

Stimulant treatment in Maryland public schools.

Safer DJ, Malever M.

Pediatrics. 2000 Sep;106(3):533-9.

PMID:
10969099
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk